A team of researchers associated with several institutions in the U.K., Germany and the U.S. has found evidence of an unusual kind of copper and iron in the brains of Alzheimer's patients. In their paper published in the ...
Fusobacterium nucleatum (F. nucleatum) is a common type of bacteria that proliferates in periodontal disease. It affects the gums and jawbone, and if untreated results in unstable teeth and tooth loss. In recent years, F. ...
Jul 12, 2022
0
24
A breakthrough in our understanding of Alzheimer's disease has revealed changes to blood vessels in the brain, potentially presenting a path for developing new drugs to help fight the disease, according to University of Manchester ...
Jun 20, 2022
0
1286
A large study led by Lund University in Sweden has shown that people with Alzheimer's disease can now be identified before they experience any symptoms. It is now also possible to predict who will deteriorate within the next ...
Nov 11, 2022
0
104
What can reading 26,000 books tell researchers about how language environment affects language behavior? Brendan T. Johns, an assistant professor of communicative disorders and sciences in the University at Buffalo's College ...
Oct 25, 2019
2
183
Scientists at the Laboratoire des Maladies Neurodégénératives (CNRS/CEA/Université Paris-Saclay) and the Neurocentre Magendie (INSERM/Université de Bordeaux) have just shown that a metabolic pathway plays a determining ...
Mar 3, 2020
0
13
A new QIMR Berghofer study has added weight to the potential benefits of using ultrasound treatment to deliver disease-targeting drugs to Alzheimer's patients.
Apr 10, 2020
0
498
Alzheimer's disease, the main cause of dementia in the elderly, is a neurodegenerative disease caused by the irreversible destruction of neuronal networks in certain brain structures affecting memory. While some risk factors ...
Mar 12, 2020
1
578
Millions of people around the world use proton pump inhibitors for conditions like heartburn, gastritis and stomach ulcers. Researchers at Karolinska Institutet in Sweden now report that the long-term use of these drugs could ...
May 8, 2020
0
464
If we can overcome the loss of a process in the brain called "RNA editing," we may be able to slow the progress of Alzheimer's disease and other synaptic disorders, a new study has shown.
Feb 28, 2020
0
160
